Status:
COMPLETED
Medical Education for Sepsis Source Control and Antibiotics
Lead Sponsor:
Center for Sepsis Control and Care, Germany
Conditions:
Sepsis
Shock, Septic
Eligibility:
All Genders
Phase:
NA
Brief Summary
Patients with severe sepsis or septic shock suffer from life-threatening infections. Fast and adequate therapy with antibiotics is crucial for survival. Current guidelines recommend the application of...
Detailed Description
This study is a cluster randomized trial (CRT) where the hospitals are the clusters. 44 hospitals in Germany have confirmed their participation. Hospitals are randomized into two groups: a control and...
Eligibility Criteria
Inclusion
- For the hospitals (cluster):
- Involved in the primary care of patients with severe sepsis/septic shock
- Willing to participate in a guideline implementation process
- For the patients:
- New onset of suspicion of severe sepsis or septic shock in the following settings:
- Prehospital
- Emergency department
- Operating theatre
- Regular ward
- Intensive care unit (ICU)/Intermediate Care Unit (IMC)
Exclusion
- For the hospitals (cluster):
- No intensive care unit available
- no acute care for patients with severe sepsis and septic shock
- For the patients:
- Start of sepsis therapy in a non-study site
- Patients not admitted to the ICU/IMC
- No commitment to full medical support (i.e. DNR)
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
4138 Patients enrolled
Trial Details
Trial ID
NCT01187134
Start Date
July 1 2011
End Date
July 1 2013
Last Update
August 9 2017
Active Locations (42)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätklinikum Aachen
Aachen, Germany
2
Ilm-Kreis-Kliniken Arnstadt-Ilmenau GmbH
Arnstadt, Germany
3
HELIOS Klinikum Aue
Aue, Germany
4
Zentralklinik Bad Berka GmbH
Bad Berka, Germany